CXCL5 and neoplasm: In hormone-independent prostate cancer, CXCL5 (also known as ENA78) enhances EGR1 transcription via the RAF–MEK–ERK pathway, thus increasing SNAIL expression, tumor cell metastasis, and EMT (28).